I now have comprehensive data from multiple authoritative textbooks and current CDC/WHO sources. Let me compose the full answer.
Hepatitis B Vaccine Safety in Children
Yes - the hepatitis B (HepB) vaccine is safe for children. It has one of the longest and best-documented safety records of any vaccine in use, with hundreds of millions of doses given to infants and children worldwide since the late 1980s. Multiple authoritative sources - the CDC, WHO, the AAP Red Book, and major medical textbooks - consistently confirm its safety profile.
What the Vaccine Is
The HepB vaccine uses recombinant DNA technology - the gene encoding hepatitis B surface antigen (HBsAg) is inserted into yeast cells to produce the antigen. Three formulations are available in the US: Recombivax HB (licensed 1986), Engerix-B (licensed 1989), and HEPLISAV-B (licensed 2017, adults only). Aluminum hydroxide is used as an adjuvant. No live virus is used, so the vaccine cannot cause hepatitis B infection. - Sleisenger & Fordtran's Gastrointestinal and Liver Disease, p. 1492
Safety Profile
"No serious side effects of the HBV vaccine have been reported."
- Sleisenger & Fordtran's Gastrointestinal and Liver Disease, p. 1492
Common, mild reactions (not dangerous):
| Reaction | Frequency |
|---|
| Pain/soreness at injection site | Most common |
| Mild low-grade fever | Occasional |
| Fatigue, headache | Rare |
These reactions are self-limiting and resolve within 1-2 days. They are not contraindications to completing the vaccine series.
Importantly, the following are NOT contraindications to the Hepatitis B vaccine in children:
-
Stable neurologic conditions (e.g., cerebral palsy, well-controlled seizures, developmental delay)
-
Autoimmune disease
-
Mild acute illness with or without fever
-
Preterm birth (with specific scheduling considerations for low birth weight infants)
-
Harriet Lane Handbook, 23rd ed., Table 16.4
Recommended Schedule for Children
The standard 3-dose schedule per the AAP Red Book 2021 is:
| Dose | Timing |
|---|
| Dose 1 | At birth (within 24 hours for infants born to HBsAg-positive mothers; within 24 hours or by 2 months for HBsAg-negative mothers per 2025 CDC update) |
| Dose 2 | 1-2 months of age |
| Dose 3 | 6-18 months of age |
2025 CDC Update: As of December 2025, for infants born to mothers who test
negative for hepatitis B, the
CDC now allows shared clinical decision-making on the birth dose timing. If the birth dose is delayed, the first dose should be given
no earlier than 2 months of age. This change does NOT affect infants born to HBsAg-positive or unknown-status mothers - those infants still require the birth dose within
12 hours of birth, along with Hepatitis B Immune Globulin (HBIG).
Why Vaccination Matters in Children
- Perinatal transmission (mother to child) is the most common route of HBV infection globally, and infection acquired in infancy is much more likely to become chronic (90% risk in infants vs. ~5% in adults)
- The WHO reported global HBV prevalence in children under 5 was 0.6% in 2024 - still above the 2030 target of 0.1% in many regions
- A birth dose is highly effective at preventing perinatal transmission
- In children and immunocompetent individuals, a booster dose is not recommended after completing the primary series, as immunologic memory persists even when antibody titers fall - Sleisenger & Fordtran, p. 1493
The Only True Contraindication
The only true contraindication is a prior anaphylactic reaction to the vaccine or any of its components (including yeast, as the vaccine is produced in yeast cells). A yeast allergy alone is not a contraindication unless it was anaphylactic. - Red Book 2021
Summary
The HepB vaccine is safe, well-tolerated, and protective in children from birth onward. Decades of global use covering hundreds of millions of doses have confirmed its excellent safety record. The small risk of mild local reactions is far outweighed by the benefit of preventing a disease that can cause chronic liver infection, cirrhosis, and liver cancer. The 2025 CDC update gives some flexibility around the birth dose timing for low-risk infants, but the complete 3-dose series remains universally recommended for all children.